Report #2874156

Received Nov 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 0.2 yrs
State: FL
Recovered: Recovered
Vaccinated: Oct 29, 2025
Onset: Oct 29, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
DTAP	DTAP (INFANRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	5KR3R	LL

Symptoms (1)

Rash

Symptom narrative

Rash on the whole left thigh of their body; This non-serious case was reported by the other health professional via call center representative and described the occurrence of rash in a 2-month-old male patient who received DTPa (Infanrix) (batch number 5KR3R, expiry date 06-FEB-2027) for prophylaxis. On 29-OCT-2025, the patient received Infanrix (left thigh). On 29-OCT-2025, 4 hrs after receiving Infanrix, the patient experienced rash (Verbatim: Rash on the whole left thigh of their body). On 29-OCT-2025, the outcome of the rash was resolved. It was unknown if the reporter considered the rash to be related to Infanrix and Infanrix Pre-Filled Syringe Device. It was unknown if the company considered the rash to be related to Infanrix and Infanrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 19-NOV-2025